Immunome (IMNM)
NASDAQ:IMNM
US Market
Holding IMNM?
Track your performance easily

Immunome (IMNM) Ownership - Who Owns Immunome?

193 Followers

Immunome (IMNM) Ownership Overview

1.57%21.08%0.67%11.85%64.83%
0.67% Other Institutional Investors
11.85% ETFs
64.83% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 33.60% of the company’s stock is owned by Institutional Investors, 1.57% is owned by Insiders, and 64.83% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 20, 2024
xxxxxxxxxxxxx
$230224
Aug 19, 2024
xxxxxxxxxxxxx
$97580
Aug 19, 2024
xxxxxxxxxxxxx
$49054
May 22, 2024
xxxxxxxxxxxxx
$27120

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$3252480
Jun 30, 2024
xxxxxxxxxxxxx
$11166993

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,935,750Institution4.89%38,106,035
2,359,983Institution3.93%30,632,579
2,173,594Institution3.62%28,213,250
2,041,991Institution3.40%26,505,043
1,504,760Institution2.51%19,531,785
1,127,729Institution1.88%14,637,922
1,039,001Institution1.73%13,486,233
922,892Institution1.54%11,979,138
797,131Institution1.33%10,346,760
726,409Institution1.21%9,428,789

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,359,983Institution3.93%30,632,579
2,041,991Institution3.40%26,505,043
1,504,760Institution2.51%19,531,785
1,127,729Institution1.88%14,637,922
797,131Institution1.33%10,346,760
726,409Institution1.21%9,428,789
548,770Institution0.91%7,123,035
512,683Institution0.85%6,654,625
448,244Institution0.75%5,818,207
394,182Institution0.66%5,116,482

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,638,089Institution2.73%23,948,861
1,411,198Institution2.35%18,317,350
981,963Institution1.64%12,313,816
832,246Institution1.39%12,167,437
462,318Institution0.77%6,000,888
410,342Institution0.68%5,326,239
235,067Institution0.39%3,436,680
258,292Institution0.43%3,238,982
129,332Institution0.22%1,890,834
117,257Institution0.20%1,521,996

FAQ

Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 0.67% of the company's stock is held by institutional investors, 1.57% is held by insiders, and 64.83% is held by retail investors.
    What percentage of Immunome (IMNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.67% of Immunome (IMNM) stock is held by institutional investors.
      What percentage of Immunome (IMNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 64.83% of Immunome (IMNM) stock is held by retail investors.
        Who owns the most shares of Immunome (IMNM)?
        Vanguard owns the most shares of Immunome (IMNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis